RPG Investment Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
RPG Investment Advisory's NVO Position: Q1 2026 in Review
RPG Investment Advisory increased its Novo Nordisk (NVO) stake by 14% in Q1 2026, buying an estimated $1.49M and bringing the position to 260,620 shares worth $9.58M. The position accounts for 1.16% of the portfolio, ranked #39.
RPG Investment Advisory first reported a position in NVO in Q3 2024 and has held it in 7 quarters since. The position peaked at $12.9M in Q1 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- RPG Investment Advisory held 260,620 shares of Novo Nordisk worth $9.58M as of Q1 2026.
- RPG Investment Advisory bought 31,355 Novo Nordisk shares in Q1 2026, an estimated $1.49M.
- Novo Nordisk made up 1.16% of RPG Investment Advisory's portfolio in Q1 2026, its #39 holding.
- RPG Investment Advisory first reported a position in Novo Nordisk in Q3 2024 and has held it in 7 quarters since.
- RPG Investment Advisory's Novo Nordisk position peaked at $12.9M in Q1 2025.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on RPG Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.